PAPER Podger L, Stewart WF, Serrano D, Lipton RB, Gomez-Ulloa D, Ayasse ND, Barnes FB, Davis EA, Runken MC

Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.

J Alzheimers Dis. 2024;98(3):1079-1094. PubMed.

PAPER Ceyzériat K, Jaques E, Gloria Y, Badina A, Millet P, Koutsouvelis N, Dipasquale G, Frisoni GB, Zilli T, Garibotto V, Tournier BB

Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.

J Alzheimers Dis. 2024;98(3):1001-1016. PubMed.

PAPER Ramadan FA, Arani G, Jafri A, Thompson T, Bland VL, Renquist B, Raichlen DA, Alexander GE, Klimentidis YC

Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.

J Alzheimers Dis. 2024;98(3):1069-1078. PubMed.

PAPER Giorelli M, Accavone D, De Liso A

Is Alzheimer's disease an individual-centered disease? Hypotheses from the atomic levels up to mathematical models for biological systems.

Front Neurol. 2024;15:1352261. Epub 2024 Feb 28 PubMed.

PAPER

Corrigendum: Sorl1 knockout inhibits expression of brain-derived neurotrophic factor: involvement in the development of late-onset Alzheimer's disease.

Neural Regen Res. 2024 Oct 1;19(10):2211. PubMed.

PAPER Li D, Jia J, Zeng H, Zhong X, Chen H, Yi C

Efficacy of exercise rehabilitation for managing patients with Alzheimer's disease.

Neural Regen Res. 2024 Oct 1;19(10):2175-2188. Epub 2023 Dec 21 PubMed.

PAPER Dematteis G, Tapella L, Lim D

Probing the endoplasmic reticulum-mitochondria interaction in Alzheimer's disease: searching far and wide.

Neural Regen Res. 2024 Oct 1;19(10):2103-2104. Epub 2024 Jan 8 PubMed.

PAPER Langley PC

Rejecting False Claims from Markov Simulations in Alzheimer's Disease.

Innov Pharm. 2023;14(3) Epub 2023 Nov 9 PubMed.

PAPER Gasparini M, Scandola M, Amato S, Salati E, Facci E, Gobbetto V, Bruno G, Vanacore N, Gambina G, Moro V

Correction to: Normative data beyond the total scores: a process score analysis of the Rey's 15 word test in healthy aging and Alzheimer's Disease.

Neurol Sci. 2024 Jun;45(6):2947. PubMed.

PAPER Brooks WH

Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.

J Alzheimers Dis. 2024;98(3):837-857. PubMed.

PAPER Aljassabi A, Zieneldien T, Kim J, Regmi D, Cao C

Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.

J Alzheimers Dis. 2024;98(3):755-772. PubMed.

PAPER Cembran A, Fernandez-Funez P

Conformational dynamics as an intrinsic determinant of prion protein misfolding and neurotoxicity.

Neural Regen Res. 2024 Oct 1;19(10):2095-2096. Epub 2023 Dec 21 PubMed.

PAPER Li Y, Yang P, Meng R, Xu S, Zhou L, Qian K, Wang P, Cheng Y, Sheng D, Xu M, Wang T, Wu J, Cao J, Zhang Q

Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis.

Acta Pharm Sin B. 2024 Mar;14(3):1380-1399. Epub 2023 Oct 21 PubMed.

PAPER Dallmeier JD, Gober R, Vontell RT, Barreda A, Dorfsman DA, Davis DA, Sun X, Brzostowicki D, Bennett I, Garamszegi SP, Wander CM, Cohen T, Scott WK

Corpora amylacea negatively correlate with hippocampal tau pathology in Alzheimer's disease.

Front Neurosci. 2024;18:1286924. Epub 2024 Feb 29 PubMed.

PAPER Wang L, Xu Y, Fukushige T, Saidi L, Wang X, Yu C, Lee JG, Krause M, Huang L, Ye Y

Mono-UFMylation promotes misfolding-associated secretion of α-synuclein.

Sci Adv. 2024 Mar 15;10(11):eadk2542. PubMed.